VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

Influenza (H5N1 virus) vaccine with adjuvant CaPNP
Vaccine Information
  • Vaccine Name: Influenza (H5N1 virus) vaccine with adjuvant CaPNP
  • Target Pathogen: Influenza virus
  • Target Disease: Influenza (flu)
  • Type: Inactivated or "killed" vaccine
  • Status: Licensed
  • Host Species for Licensed Use: Baboon
  • Host Species as Laboratory Animal Model: Mouse
  • Antigen: influenza H5N1 = avian influenza virus
  • Preparation: CaPNPs were manufactured using our proprietary process. Briefly, inorganic salt solutions of calcium chloride, sodium citrate, and dibasic sodium phosphate were mixed at pre-determined ratios to precipitate calcium phosphate. The ratios of inorganic salt solutions were adjusted to obtain particles with mean particle sizes of 200 nm ... the vaccine (inactivated H5N1 virus) was formulated with these CaPNPs.
  • Immunization Route: Intramuscular injection (i.m.)
Host Response
References